Sorin Group announced today that its Perceval S Aortic Valve replacement has been CE marked. Unlike traditional heart valve replacements, the Perceval S is self-anchoring, which means that it does not need to be sutured into place. Because no sutures are required, using the Perceval S results in reduced procedure time for aortic valve replacements.
From the press release:
The valve’s functional component is made of bovine pericardium and is mounted on a super-elastic alloy frame. This state-of-the-art system builds on a clinically proven stentless aortic pericardial valve implanted in over 10,000 patients with proven durability and optimal hemodynamics. Clinical results in the first 180 patients implanted with Perceval S show a significant reduction in surgical procedural time for both isolated and complex aortic valve replacement with aortic cross-clamp times typically reduced by at least 50%. Perceval S leverages the reliability of gold-standard cardiac surgical results. The hemodynamic performance was outstanding with low pressure gradients and large effective orifice areas at 1 and 2 years follow-up.
Press release: Sorin Group Receives CE Mark Approval for the Innovative Self-Anchoring Aortic Heart Valve, Perceval™ S…
